Cite Filings / ORKA / 0000950170-24-089337

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Oruka Therapeutics, Inc. Filed 2024-08-01 Acc 0000950170-24-089337

Documents 1

425 Prospectus/Communication re Business Combination , abio-425-20240801.htm

Around this filing

2024-08-09 425 Prospectus/Communication re Business Combination
2024-08-01 425 Prospectus/Communication re Business Combination
2024-08-01 8-K Results of operations
2024-08-01 424B3 Prospectus
2024-08-01 10-Q Quarterly Report
2024-07-26 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2024-07-09 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading abio-425-20240801.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…